SlideShare uma empresa Scribd logo
1 de 25
The following slides are notes made by David Doherty
following a very interesting presentation on “Pricing and
evaluating Orphan Drugs – present and future” provided
by Goran Medic, Market Access Manager Europe at
Horizon Pharma Plc at the Pharma Pricing & Market
Access Europe Conference in London (the world’s largest
gathering of pharmaceutical pricing, market access and
reimbursement professionals) on the 23rd
February 2017.
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP

Mais conteúdo relacionado

Mais de 3GDR

How would the Born Mobile redesign Medicine
How would the Born Mobile redesign MedicineHow would the Born Mobile redesign Medicine
How would the Born Mobile redesign Medicine3GDR
 
Introduction to gdpr
Introduction to gdprIntroduction to gdpr
Introduction to gdpr3GDR
 
Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.43GDR
 
Alan Connor, eHealth Ireland
Alan Connor, eHealth IrelandAlan Connor, eHealth Ireland
Alan Connor, eHealth Ireland3GDR
 
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)3GDR
 
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)3GDR
 
Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...3GDR
 
5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 3GDR
 
Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...3GDR
 
The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...3GDR
 
Deriving more value from real world evidence to ensure timely access of medic...
Deriving more value from real world evidence to ensure timely access of medic...Deriving more value from real world evidence to ensure timely access of medic...
Deriving more value from real world evidence to ensure timely access of medic...3GDR
 
Early evidence development for new products - planning for reimbursement success
Early evidence development for new products - planning for reimbursement successEarly evidence development for new products - planning for reimbursement success
Early evidence development for new products - planning for reimbursement success3GDR
 
Scottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the worldScottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the world3GDR
 
Structural market access challenges anti-infectives
Structural market access challenges anti-infectivesStructural market access challenges anti-infectives
Structural market access challenges anti-infectives3GDR
 
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...3GDR
 
Why OMA... Why Now?
Why OMA... Why Now?Why OMA... Why Now?
Why OMA... Why Now?3GDR
 
Global Pricing and Tender Management: How can i optimise my commercial strate...
Global Pricing and Tender Management: How can i optimise my commercial strate...Global Pricing and Tender Management: How can i optimise my commercial strate...
Global Pricing and Tender Management: How can i optimise my commercial strate...3GDR
 
Pharma Pricing & Market Access
Pharma Pricing & Market AccessPharma Pricing & Market Access
Pharma Pricing & Market Access3GDR
 
UHealth in Korea for Health and Wellness by Jongtae Park
UHealth in Korea for Health and Wellness by Jongtae ParkUHealth in Korea for Health and Wellness by Jongtae Park
UHealth in Korea for Health and Wellness by Jongtae Park3GDR
 
Catalan mHealth hub: connecting mHealth
Catalan mHealth hub: connecting mHealthCatalan mHealth hub: connecting mHealth
Catalan mHealth hub: connecting mHealth3GDR
 

Mais de 3GDR (20)

How would the Born Mobile redesign Medicine
How would the Born Mobile redesign MedicineHow would the Born Mobile redesign Medicine
How would the Born Mobile redesign Medicine
 
Introduction to gdpr
Introduction to gdprIntroduction to gdpr
Introduction to gdpr
 
Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4Irish HSE EHR strategic business case master briefing deck v1.4
Irish HSE EHR strategic business case master briefing deck v1.4
 
Alan Connor, eHealth Ireland
Alan Connor, eHealth IrelandAlan Connor, eHealth Ireland
Alan Connor, eHealth Ireland
 
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
Can mobiles save lives by Dr Line Kleinebreil (WHO Consultant)
 
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
Request for Expressions of Interest: The EU mHealth Hub (17 August 2017)
 
Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...Things you need to know about info governance to sell healthtech products int...
Things you need to know about info governance to sell healthtech products int...
 
5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare 5G World: Better Networks for Better Healthcare
5G World: Better Networks for Better Healthcare
 
Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...Digital Health a call for Government Leadership and cooperation between ICT a...
Digital Health a call for Government Leadership and cooperation between ICT a...
 
The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...The importance of post-marketing registries for payers and regulators to mana...
The importance of post-marketing registries for payers and regulators to mana...
 
Deriving more value from real world evidence to ensure timely access of medic...
Deriving more value from real world evidence to ensure timely access of medic...Deriving more value from real world evidence to ensure timely access of medic...
Deriving more value from real world evidence to ensure timely access of medic...
 
Early evidence development for new products - planning for reimbursement success
Early evidence development for new products - planning for reimbursement successEarly evidence development for new products - planning for reimbursement success
Early evidence development for new products - planning for reimbursement success
 
Scottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the worldScottish Health Intelligence - creating value for the world
Scottish Health Intelligence - creating value for the world
 
Structural market access challenges anti-infectives
Structural market access challenges anti-infectivesStructural market access challenges anti-infectives
Structural market access challenges anti-infectives
 
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...Early MA Assessment for Personalized Medicine: a framework to assess the chal...
Early MA Assessment for Personalized Medicine: a framework to assess the chal...
 
Why OMA... Why Now?
Why OMA... Why Now?Why OMA... Why Now?
Why OMA... Why Now?
 
Global Pricing and Tender Management: How can i optimise my commercial strate...
Global Pricing and Tender Management: How can i optimise my commercial strate...Global Pricing and Tender Management: How can i optimise my commercial strate...
Global Pricing and Tender Management: How can i optimise my commercial strate...
 
Pharma Pricing & Market Access
Pharma Pricing & Market AccessPharma Pricing & Market Access
Pharma Pricing & Market Access
 
UHealth in Korea for Health and Wellness by Jongtae Park
UHealth in Korea for Health and Wellness by Jongtae ParkUHealth in Korea for Health and Wellness by Jongtae Park
UHealth in Korea for Health and Wellness by Jongtae Park
 
Catalan mHealth hub: connecting mHealth
Catalan mHealth hub: connecting mHealthCatalan mHealth hub: connecting mHealth
Catalan mHealth hub: connecting mHealth
 

Último

Essentials of a Valid Transfer.pptxmmmmmm
Essentials of a Valid Transfer.pptxmmmmmmEssentials of a Valid Transfer.pptxmmmmmm
Essentials of a Valid Transfer.pptxmmmmmm2020000445musaib
 
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptxPamelaAbegailMonsant2
 
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptxMOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptxRRR Chambers
 
CAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsCAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsAurora Consulting
 
Chp 1- Contract and its kinds-business law .ppt
Chp 1- Contract and its kinds-business law .pptChp 1- Contract and its kinds-business law .ppt
Chp 1- Contract and its kinds-business law .pptzainabbkhaleeq123
 
PPT- Voluntary Liquidation (Under section 59).pptx
PPT- Voluntary Liquidation (Under section 59).pptxPPT- Voluntary Liquidation (Under section 59).pptx
PPT- Voluntary Liquidation (Under section 59).pptxRRR Chambers
 
Appeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdfAppeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdfPoojaGadiya1
 
Shubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptxShubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptxShubham Wadhonkar
 
Introduction to Corruption, definition, types, impact and conclusion
Introduction to Corruption, definition, types, impact and conclusionIntroduction to Corruption, definition, types, impact and conclusion
Introduction to Corruption, definition, types, impact and conclusionAnuragMishra811030
 
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptx
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptxpnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptx
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptxPSSPRO12
 
LITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULELITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULEsreeramsaipranitha
 
一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书E LSS
 
The doctrine of harmonious construction under Interpretation of statute
The doctrine of harmonious construction under Interpretation of statuteThe doctrine of harmonious construction under Interpretation of statute
The doctrine of harmonious construction under Interpretation of statuteDeepikaK245113
 
Human Rights_FilippoLuciani diritti umani.pptx
Human Rights_FilippoLuciani diritti umani.pptxHuman Rights_FilippoLuciani diritti umani.pptx
Human Rights_FilippoLuciani diritti umani.pptxfilippoluciani9
 
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdf
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdfBPA GROUP 7 - DARIO VS. MISON REPORTING.pdf
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdflaysamaeguardiano
 
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)Delhi Call girls
 
一比一原版利兹大学毕业证学位证书
一比一原版利兹大学毕业证学位证书一比一原版利兹大学毕业证学位证书
一比一原版利兹大学毕业证学位证书E LSS
 
一比一原版西澳大学毕业证学位证书
 一比一原版西澳大学毕业证学位证书 一比一原版西澳大学毕业证学位证书
一比一原版西澳大学毕业证学位证书SS A
 
THE FACTORIES ACT,1948 (2).pptx labour
THE FACTORIES ACT,1948 (2).pptx   labourTHE FACTORIES ACT,1948 (2).pptx   labour
THE FACTORIES ACT,1948 (2).pptx labourBhavikaGholap1
 

Último (20)

Essentials of a Valid Transfer.pptxmmmmmm
Essentials of a Valid Transfer.pptxmmmmmmEssentials of a Valid Transfer.pptxmmmmmm
Essentials of a Valid Transfer.pptxmmmmmm
 
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
8. SECURITY GUARD CREED, CODE OF CONDUCT, COPE.pptx
 
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptxMOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
MOCK GENERAL MEETINGS (SS-2)- PPT- Part 2.pptx
 
CAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction FailsCAFC Chronicles: Costly Tales of Claim Construction Fails
CAFC Chronicles: Costly Tales of Claim Construction Fails
 
Chp 1- Contract and its kinds-business law .ppt
Chp 1- Contract and its kinds-business law .pptChp 1- Contract and its kinds-business law .ppt
Chp 1- Contract and its kinds-business law .ppt
 
PPT- Voluntary Liquidation (Under section 59).pptx
PPT- Voluntary Liquidation (Under section 59).pptxPPT- Voluntary Liquidation (Under section 59).pptx
PPT- Voluntary Liquidation (Under section 59).pptx
 
Appeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdfAppeal and Revision in Income Tax Act.pdf
Appeal and Revision in Income Tax Act.pdf
 
Shubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptxShubh_Burden of proof_Indian Evidence Act.pptx
Shubh_Burden of proof_Indian Evidence Act.pptx
 
Introduction to Corruption, definition, types, impact and conclusion
Introduction to Corruption, definition, types, impact and conclusionIntroduction to Corruption, definition, types, impact and conclusion
Introduction to Corruption, definition, types, impact and conclusion
 
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptx
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptxpnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptx
pnp FIRST-RESPONDER-IN-CRIME-SCENEs.pptx
 
LITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULELITERAL RULE OF INTERPRETATION - PRIMARY RULE
LITERAL RULE OF INTERPRETATION - PRIMARY RULE
 
一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书一比一原版牛津布鲁克斯大学毕业证学位证书
一比一原版牛津布鲁克斯大学毕业证学位证书
 
The doctrine of harmonious construction under Interpretation of statute
The doctrine of harmonious construction under Interpretation of statuteThe doctrine of harmonious construction under Interpretation of statute
The doctrine of harmonious construction under Interpretation of statute
 
Human Rights_FilippoLuciani diritti umani.pptx
Human Rights_FilippoLuciani diritti umani.pptxHuman Rights_FilippoLuciani diritti umani.pptx
Human Rights_FilippoLuciani diritti umani.pptx
 
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
Russian Call Girls Rohini Sector 6 💓 Delhi 9999965857 @Sabina Modi VVIP MODEL...
 
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdf
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdfBPA GROUP 7 - DARIO VS. MISON REPORTING.pdf
BPA GROUP 7 - DARIO VS. MISON REPORTING.pdf
 
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
WhatsApp 📞 8448380779 ✅Call Girls In Nangli Wazidpur Sector 135 ( Noida)
 
一比一原版利兹大学毕业证学位证书
一比一原版利兹大学毕业证学位证书一比一原版利兹大学毕业证学位证书
一比一原版利兹大学毕业证学位证书
 
一比一原版西澳大学毕业证学位证书
 一比一原版西澳大学毕业证学位证书 一比一原版西澳大学毕业证学位证书
一比一原版西澳大学毕业证学位证书
 
THE FACTORIES ACT,1948 (2).pptx labour
THE FACTORIES ACT,1948 (2).pptx   labourTHE FACTORIES ACT,1948 (2).pptx   labour
THE FACTORIES ACT,1948 (2).pptx labour
 

Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future” by the European Market Access Manager at Horizon Pharma PLC $HZNP

  • 1. The following slides are notes made by David Doherty following a very interesting presentation on “Pricing and evaluating Orphan Drugs – present and future” provided by Goran Medic, Market Access Manager Europe at Horizon Pharma Plc at the Pharma Pricing & Market Access Europe Conference in London (the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals) on the 23rd February 2017.